Photo of Henry  Gewirtz, MD

Henry Gewirtz, MD

  • Director, Nuclear Cardiology Division








Centers & Specialties

Heart Center

Clinical Interests
  • Ischemic heart disease
  • Nuclear cardiology
  • Cardiology
Medical Education
  • MD, State University of New York at Buffalo
  • Residency, Washington VA Hospital
  • Fellowship, Massachusetts General Hospital|Fellowship, Victoria General Hospital
Board Certifications
  • Internal Medicine
  • Cardiovascular Disease
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group


1967 AB Colgate U, Hamilton,NY; 1971 MD SUNY Buffalo-School of Med, Buffalo,NY

1971-72 Intern Med, BU Hosp, Boston; 1972-74 USPHS-Union,WV

1974-75 JAR Med Georgetown-VAH, Washington,DC; 1975-77 Cardiol, Victoria Gen Hosp, Halifax,NS;

1977-78 Clin/Rsh fellow (Cardiol) MGH: 1991-92 Fellow (PET), MGH

Research & Publications

Research Summary

From 1978 until 1993 the bulk of my time was devoted to basic research concerning physiological mechanisms active in regulation of myocardial blood flow primarily in the setting of a coronary artery stenosis. These experiments were performed in a closed chest, swine model of ischemic heart disease, which I developed at Rhode Island Hospital (Brown University). After leaving Brown in 1993 to assume the role of Director, Nuclear Cardiology at MGH, I have employed PET methodology to continue my work in the physiology of the coronary circulation now in human subjects. These studies focus on mechanisms active in the regulation of myocardial blood flow and oxygen consumption not only in ischemic heart disease but also in healthy subjects as well as in patients with microvascular and mitochondrial disease. More recent clinically oriented work has been directed as use of quantitative measurements of adenosine stimulated myocardial blood flow (MBF) for diagnosis of extent and severity of CAD. Work also is in progress for validation, both in swine and human subjects, of a new F-18 labeled tracer for quantitative PET measurements of MBF.


GEWIRTZ H et al:PET Measurement of Adenosine-Stimulated Myocardial Blood Flow vs Relative Tracer Content for Assessment of Coronary Stenosis Severity.J Am Coll Cardiol Img 2009;2:751.

GEWIRTZ H et al:Myocardial Blood Flow and Oxygen Consumption in Friedreich's Ataxia.Coronary Artery Disease 2007;18:15

GEWIRTZ H: Regulating Myocardial Blood Flow in Normal and Diseased States.Current Cardiology Reports 2009;11:117

GEWIRTZ H: Cardiac PET: Measurement of Myocardial Blood Flow.In: Diagnostic Imaging of CAD (Ed. Abela GS) Lippincott,Williams and Wilkins, Philadel, PA,2009


Cardiac Unit Associates
55 Fruit Street
Boston, MA 02114-2696
Phone 1: 617-724-3651
Phone 2: 617-724-6760
Fax: 617-724-1639

Back to Top